Product

CMAB818

Aliases

Ranibizumab Injection

1 clinical trial

1 indication

Indication

Age-related Macular Degeneration

Clinical trial

A Randomized, Double-blind, Two-group Parallel, Positive-controlled Clinical Phase I Trial Comparing the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of CMAB818 and Lucentis® in Patients With Wet Age-related Macular Degeneration.

Status: Completed, Estimated PCD: 2022-12-22